The full results of a clinical trial for the Pfizer-BioNTech Covid-19 vaccine were published in the New England Journal of Medicine on Thursday, a major milestone that came as a committee of the US Food and Drug Administration met to discuss its approval.
An editorial related to the scientific paper said: "The trial results are impressive enough to hold up in any conceivable analysis. This is a triumph."
The full trial included almost 44,000 volunteers, several thousand more than the number seen in prior analyses. Around half received the vaccine and the rest a placebo.
The paper confirmed that a two-dose regimen of BNT162b2 was 95 percent effective in preventing Covid-19 infection.
The vaccine worked similarly across "age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions," the paper said.
Among 10 cases of severe Covid-19 after the first dose, nine occurred in placebo recipients and one in a person who received the vaccine.
The editorial that accompanied the study did flag certain "minor issues."
"The number of severe cases of Covid-19 (one in the vaccine group and nine in the placebo group) is too small to draw any conclusions about whether the rare cases that occur in vaccinated persons are actually more severe," it said.
Other questions include whether unexpected safety issues may arise when the number of people vaccinated grows to millions and possibly billions of people.
Also unknown is whether more side effects will emerge with longer follow-up, how long the vaccine remains effective, whether it will limit transmission, and how it will work in children, pregnant women, and immunocompromised patients.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Pfizer Far Less Effective For Delta Variant Than Earlier Strains: Lancet Study Pfizer Says Talks Underway With Centre On Bringing Covid Vaccine To India Brazil Orders 100 Million Doses Of Pfizer COVID-19 Vaccine Amid Huge Row, Karnataka Pauses Bill For Reservation In Private Sector Firms Travel Influencer Aanvi Kamdar Dies After Falling Off A Waterfall Near Mumbai Kiran Mazumdar-Shaw Opposes Karnataka's Job Quota Bill, Minister Responds On Camera, Jagan Reddy's Party Member Hacked To Death On Busy Andhra Road QS Executive MBA Rankings 2024: IIM Bangalore Tops Among Indian Institutes US Cop Who Laughed After Indian Student Jaahnavi Kandula's Death Fired Track Latest News Live on NDTV.com and get news updates from India and around the world.